Similar articles

• Enterococcal superinfection in patients treated with ciprofloxacin.

  Zervos MJ, Bacon AE 3rd, Patterson JE, Schaberg DR, Kauffman CA. Zervos MJ, et al. J Antimicrob Chemother. 1988 Jan;21(1):113-5. doi: 10.1093/jac/21.1.113. J Antimicrob Chemother. 1988. PMID: 3128516
• Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.

  Johnson M, Miniter P, Andriole VT. Johnson M, et al. J Infect Dis. 1987 Apr;155(4):783-8. doi: 10.1093/infdis/155.4.783. J Infect Dis. 1987. PMID: 3102631
• Bacteriologic and clinical findings in acute pneumonia of childhood.

  Rapkin RH. Rapkin RH. Clin Pediatr (Phila). 1975 Feb;14(2):130-3. doi: 10.1177/000992287501400203. Clin Pediatr (Phila). 1975. PMID: 234315 No abstract available.
• Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.

  Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E; Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient. Cantón R, et al. Clin Microbiol Infect. 2005 Sep;11(9):690-703. doi: 10.1111/j.1469-0691.2005.01217.x. Clin Microbiol Infect. 2005. PMID: 16104983 Review.
• Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae.

  Boulnois GJ. Boulnois GJ. J Gen Microbiol. 1992 Feb;138(2):249-59. doi: 10.1099/00221287-138-2-249. J Gen Microbiol. 1992. PMID: 1564436 Review. No abstract available.